Stock Groups

WHO experts back using malaria vaccine on African children By Reuters

© Reuters. FILEPHOTO: This logo can be seen at Geneva’s World Health Organization (WHO), building, 02/02/2019. REUTERS/Denis Balibouse

NAIROBI/DAKAR – The World Health Organization (WHO), Wednesday said that the only vaccine for malaria must be broadly used in Africa. This could represent a huge step towards a devastating disease that claims hundreds of thousands annually.

RTS,S or Mosquirix is the recommended vaccine. This was developed by GlaxoSmithKline, an American drugmaker (NYSE:). The WHO’s two top immunization advisory groups, Malaria Policy Advisory Group (NYSE:) and Strategic Advisory Group of Experts on Immunization (WHO:), jointly announced the decision in Geneva.

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are provided by market makers and are therefore not necessarily accurate. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.